Stockreport

A Look At Praxis Precision Medicines (PRAX) Valuation After FDA Priority Review For Relutrigine [Yahoo! Finance]

Praxis Precision Medicines, Inc.  (PRAX) 
PDF Praxis Precision Medicines (PRAX) recently drew attention after the FDA accepted its New Drug Application for relutrigine with priority review for SCN2A and SCN8A devel [Read more]